-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Re: BBC E-mail: Fears over premature birth drug From: Elrod, Darryl G MAJ 48 MDOS/SGOBO (Darryl.elrod@LAKENHEATH.AF.MIL) Tue Jan 17 06:27:35 2006 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: art fougner, md: "GYN: IP Chemo - Back To The Future" Previous message: art fougner, md: "Re: BBC E-mail: Fears over premature birth drug" Maybe in reply to: Gail Neuman: "BBC E-mail: Fears over premature birth drug" Next in thread: DoctorJoe@aol.com: "Re: BBC E-mail: Fears over premature birth drug" So are they suggesting we switch to cleocin for treatment of symptomatic BV? I can't imagine many women with symptomatic BV electing to not have treatment. Glen //SIGNED// D. Glen Elrod, Maj., USAF, MC Obstetrician/Gynecologist Chief of Obstetrics 48 MDOS/SGOBO RAF Lakenheath, England Telephone DSN: 314-226-8130 Comm: +44 (0) 1638 52 8130 Notice of Confidentiality Under the Privacy Act of 1974, you must safeguard all information reflected on this e-mail and, if applicable, all attachments. Disclosure of information is IAW AFI 33-119, AFI 33-127, AFI 37-131, AFI 37-132, AFI 33-219, and PL 93-579" This e-mail message including any attachments is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message. Any questions pertaining to disclosure should be directed to the privacy officer. -----Original Message----- From: ob-gyn-l@obgyn.net [mailto:ob-gyn-l@obgyn.net] On Behalf Of art fougner, md Sent: Tuesday, January 17, 2006 1:22 PM To: Multiple recipients of list OB-GYN-L Subject: Re: BBC E-mail: Fears over premature birth drug Okun et al found a similar effect of metronidazole on the incidence of preterm birth. Obstet Gynecol. 2005 Apr;105(4):857-68. Art At Tue, 17 Jan 2006, Gail Neuman wrote: > >-- >Gail Neuman saw this story on BBC News Online and thought you >should see it. > >** Message ** >Thoughts on this welcomed! > >** Fears over premature birth drug ** >A drug for pregnant women at risk of a premature birth may actually do more harm than good, a study says. >< http://news.bbc.co.uk/go/em/fr/-/1/hi/health/4607344.stm > > >** BBC Daily E-mail ** >Choose the news and sport headlines you want - when you want them, all >in one daily e-mail >< http://www.bbc.co.uk/dailyemail/ > > >** Disclaimer ** >The BBC is not responsible for the content of this e-mail, and anything written in this e-mail does not necessarily reflect the BBC's views or opinions. Please note that neither the e-mail address nor name of the sender have been verified. > >If you do not wish to receive such e-mails in the future or want to know more about the BBC's Email a Friend service, please read our frequently asked questions. http://news.bbc.co.uk/1/hi/help/4162471.stm > -- art fougner, md "I knew I was going to take the wrong train, so I left early." Lawrence Peter Berra Next message: art fougner, md: "GYN: IP Chemo - Back To The Future" Previous message: art fougner, md: "Re: BBC E-mail: Fears over premature birth drug" Maybe in reply to: Gail Neuman: "BBC E-mail: Fears over premature birth drug" Next in thread: DoctorJoe@aol.com: "Re: BBC E-mail: Fears over premature birth drug"

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Jul 2 04:42:21 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.